4-epi-vancosaminyl derivative of vancomycin

The 4-epi-vancosaminyl derivative of vancomycin is a modified glycopeptide antibiotic, structurally related to the well-known antibiotic vancomycin. This derivative features a modification involving the 4-epi-vancosamine sugar moiety, which can be either an additional monosaccharide or a substitution of an existing vancosamine at position 4, as seen in related glycopeptide antibiotics like chloroeremomycin. Like vancomycin, its mechanism of action is primarily bactericidal, targeting bacterial cell wall synthesis. It achieves this by binding to the D-alanyl-D-alanine (D-Ala-D-Ala) peptide motif of the peptidoglycan precursor, thereby preventing the transglycosylation step and subsequent cross-linking necessary for the formation of a strong and stable bacterial cell wall. This disruption leads to cell lysis and bacterial death, making it effective against Gram-positive bacteria.